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INTRODUCTION:  Cronkhite  Canada  Syndrome  (CCS)  is a rare  syndrome,  described  in 1955  by Americans,
Leonard  Wolsey  Cronkhite  and  Wilma  Jeanne  Canada  in  the  New  England  Journal  of  Medicine  [1]. About
450  cases  have  been  reported.  Complications,  like malignant  transformation,  unprovoked  thromboem-
bolism  is  known.  Since  there  is  wide  variability  in  medical  presentation,  no  deﬁnitive  diagnostic  and
treatment  protocol  s  have  been  set.  The  mortality  remains  at 55%.
CASE  PRESENTATION:  We  report  a case  of  a  50 year  old  male  patient  presenting  with  diarrhea,  weight loss,
abdominal  pain,  ectodermal  features.  His  upper  (UGI)  and  lower  Gastrointestinal  (LGI)  endoscopy  showed
multiple polypoidal  and  carpet  like lesions  in  fundus,  body  and  antrum  of  stomach.  Videocolonoscopy
showed  multiple  sessile  and  pedunculated  polyps.  Multiple  biopsies  were  taken,  proving  malignancy.
Because  of  poor  nutrition,  total  parenteral  nutrition  was  given  for four  weeks.  After  nutritional  optimiza-
tion,  he  underwent  laparoscopic  assisted  subtotal  colectomy.  His  post-operative  course  was  complicated
by  the occurrence  of pulmonary  embolism  and anastomotic  leak.
DISCUSSION:  CCS  is an ailment  of  unknown  pathophysiology.  Considering  what  is known  so  far,  patients
suffering  from  CCS  are  at  highest  risk  of  thromboembolic  episodes.  This  seems  to  be  irrespective  of
surgical  intervention.  Patients  of  CCS  should  have  thromboembolic  prophylaxis  started  as soon  as  a diag-
nosis  is  made.  They  should  have  thrombophilia  proﬁle,  ﬁbrinogen  level and  Factor  8 tested  before  any
intervention  is  planned.
CONCLUSION:  If CCS  presents  with  a surgical  indication,  namely  malignancy,  the  patient  should  be cat-
egorized  as  highest  risk for  thromboembolic  complications  and  both  mechanical  and  pharmacological
prophylaxis  be  instituted.
©  2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
CCS is a diffuse gastrointestinal polyposis syndrome with
iarrhea, weight loss, abdominal pain, ectodermal ﬁndings
f onychodystrophy, alopecia, cutaneous hyper pigmentation,
ypogeusia and dysphagia [1,2]. The incidence is one per million,
s per the largest study so far [3]. Diagnosis is based on history,
hysical ﬁndings, endoscopy and histology. The etiology is probably
utoimmune or infectious because of inﬂammatory cell inﬁltra-
ion within the polyps [4]. CCS is also associated with elevated
nti-nuclear antibody (ANA) and IgG4. It is a relentlessly progres-
ive disease with a variable course and poor prognosis depending
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reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
mainly on control of protein and electrolyte balance. Mortality
exceeds 50% regardless of therapy [4].
2. Case presentation
A 50 years old male patient presented to our hospital with the
history of diarrhoea, abdominal pain and signiﬁcant weight loss
(more than ten kg) in the past two to three months. He had features
of dysnychia, skin hyper pigmentation and alopecia. (Fig. 1)
He was evaluated by upper (UGI) and lower Gastrointestinal
(LGI) endoscopy. UGI endoscopy showed multiple polypoidal and
carpet like lesions in fundus, body and antrum of stomach. Duo-
denal bulb also showed large sessile and pedunculated polypoidal
lesions involving ampulla (Fig. 2). Videocolonoscopy showed mul-
tiple small sessile and large pedunculated polyps from rectum
to caecum (Figs. 3 and 4). CT Abdomen (oral and IV radiocon-
trast) showed thickening of the stomach wall with polyps, mild
prominence of small bowel loops with wall thickening and sub-
centimeter mesenteric nodes. Multiple biopsies were taken during
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Dysnychia of hand nails.
Fig. 2. Duodenal bulb showing large sessile and pedunculated polypoidal lesions involving ampulla.
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ndoscopies. Histopathology conﬁrmed multiple hamartomatous
olyps and tubular adenomas. Few adenomas showed moderate
o high grade dysplasia (Figs. 5 and 6). Other investigations done
ere complete blood count, biochemistry, BUN and Serum Crea-
inine, albumin levels and electrolytes. He had hypoalbuminemia.
ther laboratory parameters were normal.
Because of diarrhea, intolerance to oral feeds and poor nutri-
ion, parenteral nutrition was given for four weeks. He underwent
aparoscopic subtotal colectomy with iliorectal anastomosis. He
ad a prolonged but uneventful surgery. Mechanical compression
evice for thromboembolic prophylaxis was applied intraopera-
ively. Postoperatively, he was extubated and shifted to surgical
CU for monitoring.
On day one of ICU stay, patient was hypotensive, tachycardic
nd tachypnoeic. He was saturating 88% on high ﬂow oxygen mask
ith reservoir bag. He was resuscitated with ﬂuid boluses, later
asopressor support was  started. Differential diagnosis of postop-
rative acute coronary syndrome/pulmonary embolism/sepsis was
onsidered. He had an ECG, 2D Echocardiography, serum procalci-
onin done. His procalcitonin was minimally raised. ECG showed
ight heart strain, there were a deep S in I and q wave in lead
II. 2D Echocardiography showed dilated right atrium and ventri-
le with ventricular dysfunction. A HRCT chest with pulmonary
ngiogram (CTPA) conﬁrmed thrombi in both the right and left
ain pulmonary artery (Fig. 4). Since thrombolysis was contraindi-
ated, patient was put on unfractionated heparin. He stabilized overll sessile and large pedunculated polyps.
ﬁrst week. A follow up ultrasound of his abdomen showed a large
intraperitoneal collection. An anastomotic leak was  suspected to
which he succumbed.
3. Discussion
CCS is a rare disease with unknown etiology. Since the number
of reported cases are low i.e. 450 worldwide, it has been difﬁcult
to classify this disease, set up surveillance and treatment proto-
cols. Most of the information comes from case series. Since its ﬁrst
description by Cronkhite and Canada, various additional clinical
features have been noticed. Jarnum and Jensen [9] in 1966 observed
protein losing enteropathy and electrolyte disturbances (hypocal-
caemia, hypomagnesaemia, hypokalemia). In 1972, Johnson et al.,
[10] published that the polyps in the stomach and large intes-
tine are hamartomas. Polyps are frequent in the stomach, small
and large intestine with esophageal sparing. Etiologically, evidence
states that CCS is an immune disorder. The disease is sporadic; no
hereditary links have been found though there is one case report
of its familiality [11]. CCS is linked to increase anti- nuclear anti-
bodies, [4,6] and IgG4 plasma cell inﬁltration of polyps. Immune
suppression by corticosteroids and azathioprine may  eradicate or
lessen manifestations of CCS. Juvenile polyposis syndrome (JPS), is
another condition with hamartomas, in which the polyps are dis-
tributed through the gastrointestinal tract, but mainly colorectal
and polypoidal. It is linked to mutation in BMPR1A or SMAD4 gene.
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Fig. 4. CTPA showing thrombi in both right and left main pulmonary arteries.
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dFig. 5. Multiple hamartomat
resence of one of these gene mutation helps to differentiate it
rom CCS.JPS does not have ectodermal features like onychodystro-
hy, skin hyperpigmentation. Histopathologically, polyps cannot
e differentiated from CCS. There is no deﬁnitive treatment for JPS.
The mean age of onset is estimated to be in the ﬁfth-sixth
ecade with male to female ratio of 3:2 [6]. CCS is known tolyps and tubular adenomas.
progress relentlessly and the overall prognosis remains poor. In
15% of CCS patients, stomach or colorectal cancer is identiﬁed
[4,7]. Multiple other complications like malnutrition, protein losing
enteropathy, recurrent infections, gastrointestinal bleed, adenocar-
cinoma, rib fractures, thrombosis are seen [4–8]. Indications for
surgery include malignant transformation, recurring polyps inspite
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f optimal medical management. Surgical outcomes are poor with
ortality exceeding 50% [6,8].
In a case report by Sampson et al. [6] their patient had repeated
ccurrences of pulmonary and distal arterial thrombosis inspite
f adequate duration of anticoagulation. The thrombosis recurred
ith every attempt to stop anti-coagulation. His thrombophilia
roﬁle was normal but he had an elevated level of ﬁbrinogen and
actor 8. There are other reports of venous thrombosis in CCS asso-
iated with sepsis [13] or malignancy [14]. In all these reports, CCS
as not been associated with thrombophilia but they had elevated
brinogen and Factor 8 levels. We  did not investigate our patient for
aised ﬁbrinogen and Factor 8 pre operatively. In hindsight, knowl-
dge of increased ﬁbrinogen, Factor 8 and active malignancy would
ave raised his perioperative risk of thromboembolism and both
echanical and pharmacological methods would be instituted.
. Conclusion
CCS is an ailment of unknown pathophysiology. Considering
hat is known so far, patients suffering from CCS are at highest
isk of thromboembolic episodes. This seems to be irrespective of
urgical intervention. Add to this, surgical stress is likely to aug-
ent the incidence of thrombotic events. So, patients of CCS should
ave thromboembolic prophylaxis started as soon as a diagnosis is
ade. Also, when managing CCS, patients should have their throm-
ophilia proﬁle, ﬁbrinogen level and Factor 8 tested before any
ntervention is planned.
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